Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis A | Research article

Sero-prevalence of viral hepatitis A in a district of Sri Lanka: a community based cross-sectional study

Authors: Nalin Ariyarathna, Chrishantha Abeysena

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Hepatitis A Virus (HAV) is one of the most common food and water borne infectious disease prevailing globally. The objective of the study was to determine sero-prevalence of HAV infection in a district of Sri Lanka.

Methods

This was a descriptive cross sectional study conducted on 1403 participants aged 1 year and above selected by multistage stratified (for age group and area of residence) cluster sampling from September 2015 to December, 2016. An interviewer-administered questionnaire was used to collect data and Anti-IgG testing was done to determine sero-positivity. The overall, the age and sex specific sero-prevalence of HAV were calculated with 95% confidence intervals (CI).

Results

Of the 1403 participants 1132 were anti HAV IgG positive. Therefore the overall sero-prevalence of HAV infection was 80.7% (95%CI: 78.64–82.76). There were 283 (20.2%) individuals below the age group of 14 years and below and out of them, 204 had anti HAV IgG, therefore sero-prevalence was 72.1% for that age group. The age group 15 years and aboe comprised of 1120 (79.8%) participants and of them 928 had anti HAV IgG, making sero-prevalence 82.9%. The lowest sero-prevalence (66.9%, n = 232) was observed in the age group of 11–20 years followed by 21–30 age group. From age 31 years onwards, the sero-prevalence exceeded 90%, reaching 100% after 71 years. The urban population showed a sero-prevalence of 83% (n = 195) and 80.2% (n = 937) for the rural sector while females had a sero-prevalence of 82.2% (n = 766) and it was 77.7% (n = 366) for males. Thirty-four (3.0%) participants who had sero-positive results (n = 1132) claimed that they have had HAV in the past.

Conclusions

Overall, four fifth of the population was immune to HAV infection in the district of Gampaha.
Literature
2.
go back to reference Kumar P, Clark M. Kumar and Clark's Clinical Medicine. Amsterdam: Elsevier LTD; 2009. Kumar P, Clark M. Kumar and Clark's Clinical Medicine. Amsterdam: Elsevier LTD; 2009.
5.
go back to reference Department Of Statistics. Epidemiology Unit. 2013. Department Of Statistics. Epidemiology Unit. 2013.
6.
go back to reference Ministry Of Health. Annual Health Bulletin. Sri Lanka: Ministry of Health; 2012. Ministry Of Health. Annual Health Bulletin. Sri Lanka: Ministry of Health; 2012.
7.
go back to reference Moritsugu Y, Miyamura K, Utagawa E, Kono R, De La Motte P, Forbes C. Prevalence of anti-body to hepatitis-A virus in Sri Lanka. Asian Journal Infect Dis. 1979;3(1):33–6 Available at: Accessed: 8 Mar 2013. Moritsugu Y, Miyamura K, Utagawa E, Kono R, De La Motte P, Forbes C. Prevalence of anti-body to hepatitis-A virus in Sri Lanka. Asian Journal Infect Dis. 1979;3(1):33–6 Available at: Accessed: 8 Mar 2013.
8.
go back to reference Franco E, Vitiello G. Vaccination strategies against hepatitis A in southern Europe. Vaccine. 2003;21(7-8):696–7 PubMed PMID: 12531342. Epub 2003/01/18. eng.CrossRef Franco E, Vitiello G. Vaccination strategies against hepatitis A in southern Europe. Vaccine. 2003;21(7-8):696–7 PubMed PMID: 12531342. Epub 2003/01/18. eng.CrossRef
9.
go back to reference Moser and Kalton. Researching Social Life, 1971. Moser and Kalton. Researching Social Life, 1971.
10.
go back to reference De Silva K, Weerasuriya D, Peelawattage M, Fernando S. Seroprevalence of hepatitis-antibodies in relation to social factors, a preliminary study. Ceylon Med J. 2005;50(2):54–8.CrossRef De Silva K, Weerasuriya D, Peelawattage M, Fernando S. Seroprevalence of hepatitis-antibodies in relation to social factors, a preliminary study. Ceylon Med J. 2005;50(2):54–8.CrossRef
11.
go back to reference World Health Organization. The global prevalence of Hepatitis A viral infection and susceptibility, A systematic review. Kindle ed. Geneva: World Health Organization; 2010. World Health Organization. The global prevalence of Hepatitis A viral infection and susceptibility, A systematic review. Kindle ed. Geneva: World Health Organization; 2010.
12.
go back to reference Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, et al. Seroprevalence of hepatitis-antibodies in relation to social factors, a preliminary study. Osong Public Health Res Perspect. 2012;3(1):31–5 PubMed PMID: 24159484. Pubmed Central PMCID: PMC3738681. Epub 2012/03/01. eng.CrossRef Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, et al. Seroprevalence of hepatitis-antibodies in relation to social factors, a preliminary study. Osong Public Health Res Perspect. 2012;3(1):31–5 PubMed PMID: 24159484. Pubmed Central PMCID: PMC3738681. Epub 2012/03/01. eng.CrossRef
15.
go back to reference Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India. 2006;19(4):203–17.PubMed Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India. 2006;19(4):203–17.PubMed
16.
go back to reference Fix AD, Martin OS, Gallicchio L, Vial PA, Lagos R. Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg. 2002;66(5):628–32 PubMed PMID: 12201603. Epub 2002/08/31. eng.CrossRef Fix AD, Martin OS, Gallicchio L, Vial PA, Lagos R. Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg. 2002;66(5):628–32 PubMed PMID: 12201603. Epub 2002/08/31. eng.CrossRef
17.
go back to reference Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015;87(4):569–74 PubMed PMID: 25648328. Epub 2015/02/05. eng.CrossRef Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015;87(4):569–74 PubMed PMID: 25648328. Epub 2015/02/05. eng.CrossRef
18.
go back to reference Kiyohara T, Sato T, Totsuka A, Miyamura T, Ito T, Yoneyama T. Shifting Seroepidemiology of Hepatitis A in Japan, 1973–2003. Microbiol Immunol. 2007;51(2):185–91.CrossRef Kiyohara T, Sato T, Totsuka A, Miyamura T, Ito T, Yoneyama T. Shifting Seroepidemiology of Hepatitis A in Japan, 1973–2003. Microbiol Immunol. 2007;51(2):185–91.CrossRef
19.
go back to reference Mantovani SAS, Delfino BM, Martins AC, Oliart-Guzmán H, Pereira TM, Branco FLCC, et al. Socioeconomic inequities and hepatitis A virus infection in Western Brazilian Amazonian children: spatial distribution and associated factors. BMC Infect Dis. 2015;15(1):428.CrossRef Mantovani SAS, Delfino BM, Martins AC, Oliart-Guzmán H, Pereira TM, Branco FLCC, et al. Socioeconomic inequities and hepatitis A virus infection in Western Brazilian Amazonian children: spatial distribution and associated factors. BMC Infect Dis. 2015;15(1):428.CrossRef
20.
go back to reference Mathur P, Arora N. Epidemiological transition of hepatitisA in India: Issues for vaccinationin developing countries. Indian J Med. 2008:699–704. Mathur P, Arora N. Epidemiological transition of hepatitisA in India: Issues for vaccinationin developing countries. Indian J Med. 2008:699–704.
21.
go back to reference Hollinger FB, Ticehurst JR. Hepatitis A virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott- Raven. Hollinger FB, Ticehurst JR. Hepatitis A virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott- Raven.
Metadata
Title
Sero-prevalence of viral hepatitis A in a district of Sri Lanka: a community based cross-sectional study
Authors
Nalin Ariyarathna
Chrishantha Abeysena
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4043-y

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue